| Business Summary | | E-Z-EM,
Inc.
is
primarily
engaged
in
developing,
manufacturing
and
marketing
diagnostic
products
used
by
radiologists
and
other
physicians
during
image-assisted
procedures
to
detect
anatomic
abnormalities
and
diseases.
The
Company
also
designs,
develops,
manufactures
and
markets,
through
its
wholly
owned
subsidiary,
AngioDynamics,
Inc.,
a
variety
of
therapeutic
and
diagnostic
products,
for
use
principally
in
the
diagnosis
and
treatment
of
peripheral
vascular
disease. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | E-Z-EM,
Inc.
develops,
manufactures
and
markets
diagnostic
products
used
by
radiologists
and
other
physicians
during
image-assisted
procedures
to
detect
physical
diseases
and
abnormalities,
and
a
variety
of
products
for
treatment
of
cardiovascular
disease.
For
the
39
weeks
ended
3/3/01,
net
sales
rose
less
than
1%
to
$81
million.
Net
income
fell
32%
to
$2.8
million.
Results
reflect
higher
AngioDynamics
products
sales,
offset
by
lower
production
throughput. Recent Earnings Announcement For
the
3
months
ended
06/02/2001,
revenues
were
31,086;
after
tax
earnings
were
477. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| Officers | | | FY2000 Pay | |
| Howard Stern, 69 Chairman | $358K | Anthony Lombardo, 53 Pres,
CEO, Director | 42K | Dennis Curtin, 53 Sr.
VP, CFO | 217K | Joseph Palma, 58 Sr.
VP, Sales and Marketing | 222K | Arthur Zimmet, 64 Sr.
VP - Special Projects | 238K | Dollar amounts are as of 3-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|